We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+6.47%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$11B
AUM Growth
+$6.3B
Cap. Flow
-$236M
Cap. Flow %
-2.13%
Top 10 Hldgs %
41.04%
Holding
1,273
New
73
Increased
578
Reduced
348
Closed
99

Sector Composition

Rank Sector Weight
1 Real Estate 62.34%
2 Technology 7.48%
3 Consumer Discretionary 3.58%
4 Healthcare 3.49%
5 Communication Services 3.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DRNA
1051
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$8K ﹤0.01%
422
+36
+9% +$745
CGEN icon
1052
Compugen
CGEN
$212M
$7K ﹤0.01%
434
+82
+23% +$1.34K
CHRS icon
1053
Coherus Oncology
CHRS
$217M
$7K ﹤0.01%
396
GMAB icon
1054
Genmab
GMAB
$17.5B
$7K ﹤0.01%
195
+24
+14% +$868
NWS icon
1055
News Corp Class B
NWS
$17.7B
$7K ﹤0.01%
511
+488
+2,122% +$6.81K
OCFT
1056
DELISTED
OneConnect Financial Technology
OCFT
$7K ﹤0.01%
+35
New +$7.6K
RCKT icon
1057
Rocket Pharmaceuticals
RCKT
$343M
$7K ﹤0.01%
314
+30
+11% +$739
EPZM
1058
DELISTED
Epizyme, Inc
EPZM
$7K ﹤0.01%
571
LMNX
1059
DELISTED
Luminex Corp
LMNX
$7K ﹤0.01%
254
CM icon
1060
Canadian Imperial Bank of Commerce
CM
$106B
$6K ﹤0.01%
+160
New +$5.86K
ESPR
1061
DELISTED
Esperion Therapeutics
ESPR
$6K ﹤0.01%
154
LKFT
1062
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
$6K ﹤0.01%
40
INVA icon
1063
Innoviva
INVA
$1.6B
$6K ﹤0.01%
572
KPTI icon
1064
Karyopharm Therapeutics
KPTI
$155M
$6K ﹤0.01%
28
+4
+17% +$978
NTLA icon
1065
Intellia Therapeutics
NTLA
$1.51B
$6K ﹤0.01%
288
RGNX icon
1066
Regenxbio
RGNX
$616M
$6K ﹤0.01%
208
STOK icon
1067
Stoke Therapeutics
STOK
$1.84B
$6K ﹤0.01%
185
SUPN icon
1068
Supernus Pharmaceuticals
SUPN
$2.7B
$6K ﹤0.01%
296
NGM
1069
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$6K ﹤0.01%
376
ZGNX
1070
DELISTED
Zogenix, Inc.
ZGNX
$6K ﹤0.01%
315
+65
+26% +$1.59K
ADVM
1071
DELISTED
Adverum Biotechnologies
ADVM
$5K ﹤0.01%
44
AKRO
1072
DELISTED
Akero Therapeutics
AKRO
$5K ﹤0.01%
161
ALEC icon
1073
Alector
ALEC
$169M
$5K ﹤0.01%
438
AMPH icon
1074
Amphastar Pharmaceuticals
AMPH
$907M
$5K ﹤0.01%
265
ARVN icon
1075
Arvinas
ARVN
$530M
$5K ﹤0.01%
220

Similar funds

Daiwa Securities Group's Q3 2020 Portfolio in Review

As of Q3 2020, Daiwa Securities Group held 1,273 positions worth $11B, up 133% from $4.74B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Daiwa Securities Group's Q3 2020 filing shows 73 new, 578 increased, 348 reduced and 99 closed positions. Its largest new stake was Global X Cloud Computing ETF: 2,004,400 shares worth $49M. The largest sale was Digital Realty Trust, an estimated $308M.

By sector, the portfolio is most concentrated in Real Estate at 62% of assets, up from 58% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q3 2020 buy was Global X Cloud Computing ETF: 2,004,400 shares worth $49M.
  • Daiwa Securities Group added most to CyrusOne Inc Common Stock in Q3 2020, an estimated $268M increase.
  • Daiwa Securities Group's biggest Q3 2020 reduction was Digital Realty Trust, cutting an estimated $308M.
  • Daiwa Securities Group fully exited BWX Technologies in Q3 2020, selling an estimated $11.3M.
  • Daiwa Securities Group's ten largest holdings make up 41% of its $11B portfolio in Q3 2020.
  • Daiwa Securities Group opened 73 new positions and closed 99 in Q3 2020.
  • Daiwa Securities Group's portfolio value rose 133% quarter-over-quarter to $11B.

Based on Daiwa Securities Group's 13F filing for Q3 2020, filed 2 Nov 2020.